Clinical and pharmacokinetic effects of testosterone undecanoate long-term treatment in hypogonadal men

被引：0
作者：
Bueber, V [1 ]
Preuss, R [1 ]
Witte, M [1 ]
Gerke, O [1 ]
Grote, M [1 ]
Saad, F [1 ]
机构：
[1] Schering AG, D-1000 Berlin, Germany
来源：
JOURNAL OF ANDROLOGY | 2004年
关键词：
D O I：
暂无
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
14
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [21] SEXUAL FUNCTION, QUALITY OF LIFE AND METABOLIC SYNDROME PARAMETERS IN 162 OBESE HYPOGONADAL MEN UNDER LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE
    Saad, F.
    Saad, F.
    Doros, G.
    Traish, A.
    Yassin, A.
    JOURNAL OF SEXUAL MEDICINE, 2014, 11 : 72 - 72
  • [22] LONG-TERM TREATMENT OF MIDDLE-AGED TO ELDERLY HYPOGONADAL MEN WITH TESTOSTERONE UNDECANOATE DOES NOT INDICATE AN INCREASED RISK OF PROSTATE CANCER
    Farid, S.
    Doros, G.
    Haider, A.
    Yassin, A.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 354 - 354
  • [23] LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS SUSTAINABLY IMPROVES METABOLIC CONTROL AND ERECTILE FUNCTION IN HYPOGONADAL MEN WITH TYPE 2 DIABETES
    Saad, F.
    Haider, A.
    Doros, G.
    Traish, A.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 53 - 54
  • [24] BENEFICIAL EFFECTS OF LONG-TERM TESTOSTERONE REPLACEMENT THERAPY (TRT) WITH TESTOSTERONE UNDECANOATE (TU) IN HYPOGONADAL MEN WITH CARDIOVASCULAR DISEASES (CVD) IN AN OBSERVATIONAL REGISTRY STUDY
    Saad, F.
    Haider, A.
    Doros, G.
    Traish, A.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 12 - 13
  • [25] Long-Term Testosterone Undecanoate Treatment in Hypogonadal Men with Erectile Dysfunction Improves Metabolic Syndrome and Health-Related Quality of Life
    Yassin, Aksam
    Yassin, Aiman Dany-Jan
    Hammerer, Peter
    JOURNAL OF MENS HEALTH, 2014, 11 (01) : A5 - A6
  • [26] LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS LEADS TO SUSTAINED WEIGHT LOSS AND IMPROVEMENT OF METABOLIC SYNDROME PARAMETERS IN 381 HYPOGONADAL MEN
    Zitzmann, M.
    Saad, F.
    Kliesch, S.
    JOURNAL OF SEXUAL MEDICINE, 2014, 11 : 7 - 7
  • [27] Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men
    Swerdloff, RS
    Wang, C
    Cunningham, G
    Dobs, A
    Iranmanesh, A
    Matsumoto, AM
    Snyder, PJ
    Weber, T
    Longstreth, J
    Berman, N
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (12) : 4500 - 4510
  • [28] Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men
    Narayana, Nandini Shankara
    Ly, Lam P.
    Jayadev, Veena
    Fennell, Carolyn
    Savkovic, Sasha
    Conway, Ann J.
    Handelsman, David J.
    ENDOCRINE CONNECTIONS, 2021, 10 (07) : 758 - 766
  • [29] HYPOGONADAL MEN WITH PRE-EXISTING CARDIOVASCULAR DISEASE (CVD) SHOW IMPROVED ERECTILE FUNCTION ON LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS
    Saad, F.
    Doros, G.
    Haider, A.
    Traish, A.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 233 - 233
  • [30] Long-Term Treatment with Injectable Testosterone Undecanoate (TU) Improves Type 2 Diabetes (T2DM) and Mortality in Hypogonadal Men
    Saad, Farid
    Haider, Ahmad
    Doros, Gheorghe
    Traish, Abdulmaged
    DIABETES, 2016, 65 : A271 - A271
12345